CGChristopher Edward Gross

Christopher Edward Gross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christopher Edward Gross has a total of 230 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effect of Diabetes on 30-Day Complications, Readmission, and Reoperation in Patients Undergoing Below-Knee Amputation

    by Solangel Rodriguez Materon, Samantha Trynz, Joshua Morningstar, Dev Patel, Daniel J. Scott, Christopher E. Gross

    Introduction: Risk factors for early complications and reoperation in the overall population undergoing below-knee amputation (BKA) have been reported; however, there is limited literature investigating adverse postoperative outcomes specific to diabetic patients. This study compares 30-day complication, readmission, reoperation, and mortality rates following BKA in patients with and without diabetes. Methods: The ACS NSQIP database was queried from 2005 to 2019 to identify 28 776 patients undergoing BKA using current procedural terminology (CPT) codes 27880, 27881, and 27882. Of this cohort, 20 310 (70.6%) had diabetes. Postoperative outcomes, including 30-day complications, readmission, reoperation, and mortality, were compared between groups. Results: Postoperatively, diabetic patients had significantly higher rates of 30-day complications (Diabetic = 39.0%, Nondiabetic = 34.8%; P < .001), including severe complications (Diabetic = 9.12%, Nondiabetic = 8.20%; P = .012). Diabetic patients also had significantly higher rates of bleeding requiring transfusion (Diabetic = 20.4%, Nondiabetic = 15.0%; P < .001) and sepsis (Diabetic = 6.28%, Nondiabetic = 5.23%; P < .001). On multivariate analysis, diabetes independently predicted increased risk of adverse discharge to a facility (defined as discharge to a skilled nursing or rehabilitation facility rather than home; odds ratio [OR] 1.184; P < .001) but decreased odds of reoperation (OR 0.785; P < .001) and mortality (OR 0.809; P = .002). Among diabetic patients, insulin-dependent diabetic patients experienced significantly higher rates of any postoperative complication (Insulin = 39.7%, Noninsulin = 36.4%; P < .001) and readmission (Insulin = 14.1%; Noninsulin = 12.1%; P = .005), as well as increased length of stay (Insulin = 12.4 days; Noninsulin = 11.6 days; P = .007) compared to other diabetics. Conclusion: Diabetic patients undergoing BKA had significantly increased rates of 30-day complications, including severe complications, and adverse discharge to a facility. However, diabetes was independently associated with decreased odds of reoperation and mortality within 30 days. Insulin-dependent diabetic patients experienced further elevated complication and readmission rates. Given the significantly increased rates of bleeding requiring transfusion and sepsis among diabetic patients, targeted perioperative optimization strategies should be employed in this population. Level of Evidence: Level III retrospective cohort study

  • Nitinol Staples in Foot and Ankle Surgery: Current Concept Review

    by Solangel Rodriguez-Materon, W. Casey Fox, Joshua L. Morningstar, Daniel J. Scott, Christopher E. Gross

  • Does Implanted Ankle Hardware Harbor Bacteria? Identification of the Microbial Profile Using Next-Generation DNA Sequencing? A Short Report

    by Luke LaRochelle, Joshua L. Morningstar, Caroline Hoch, Solangel Rodriguez Materon, Hana Hashioka, Daniel J. Scott, Christopher E. Gross

    Background: Next-generation DNA sequencing (NGS) has improved detection of bacterial species and expanded understanding of the microbiome’s influence on postoperative outcomes in orthopaedic patients. Although NGS has identified organisms linked to reoperations in shoulder surgery, its application in the foot and ankle remains unexplored. This study uses NGS to determine whether patients undergoing hardware removal exhibit a unique microbiome profile. Methods: A prospective study recruited 34 patients undergoing hardware removal surgery from the foot or ankle during 2020-2023. Patients were excluded based on any concern for infection prior to surgery. During the operation, the surgeon collected the removed hardware for analysis at a CLIA (Clinical Laboratory Improvement Amendments of 1988)–licensed molecular diagnostic laboratory. Majority of patients underwent surgery for painful orthopaedic hardware (70.6%). The cohort was predominantly female (62.2%) and mean age was 53.3 years (range 17-78). The mean time from primary implantation to hardware removal was 40.1 months (range 2.8-276.6 months). Results: NGS identified bacterial DNA in 5 cases (14.7%), detecting 9 total organisms. Staphylococcus species were most common (44.4%), followed by Corynebacterium (22.2%). No significant associations were found between bacterial detection and patient demographics or with hardware removal performed for painful implants. Conclusion: This study found no consistent microbiome among patients undergoing hardware removal surgery, with Staphylococcus species being the most frequently detected organisms. These preliminary findings suggest that foot and ankle hardware does not consistently harbor bacteria detectable by NGS, although the small sample size limits generalizability and further investigation is warranted.

  • Open Access

    Screw Angulation and Insertion Sequence Increase Interfragmentary Compression When Using Plates for Midfoot Arthrodesis: Foam-Surrogate and Cadaveric Validation

    by James Johnson, Leah Buch, Shannon King, Mia Knauf, Joshua Kim, Christopher Gross, Daniel Scott, Samuel Adams, Kenneth Dupont, David Safranski

    Background: Achieving interfragmentary compression and stability is critical for successful bone healing in fracture fixation and arthrodesis procedures. Modern orthopaedic plating systems incorporating variable-angle screw designs offer greater versatility; however, the impact of screw trajectory on interfragmentary compression and contact area has not been adequately explored. We questioned if the resultant forces applied by screw orientation would follow the basic principles of vector geometry. Methods: Interfragmentary compression and contact area were quantified in foam bone surrogate osteotomy models using plates allowing maximum screw angulation of either 15 or 30 degrees, with screws inserted at various angles. Cadaveric second-tarsometatarsal (TMT) arthrodesis constructs were subsequently used to validate the mechanical findings from surrogate testing. Results: Compression and contact area increased from 0 degrees to 15 degrees to 30 degrees in surrogate models (overall analysis of variance P < .001). Angling screws in the second bone fragment after securing the plate to the first fragment produced the largest compression gains. In cadaveric second-TMT constructs, 30-degree divergence increased compression (~15-fold; 49.4 ± 35.1 N vs 3.4 ± 3.8 N; P < .001) and contact area (~4-fold; 47.8 ± 28.9 mm ² vs 12.8 ± 7.3 mm ² ; P < .001) compared with 0-degree divergence. Conclusion: With plate fixation, screw divergence from the arthrodesis/fracture line improved interfragmentary compression and contact area, particularly when divergent screws were inserted into the second bone fragment after the plate was secured to the first fragment. As hypothesized, the findings followed basic vector geometry. Clinical Relevance: Surgeons can optimize plate fixation quality and enhance stability in midfoot arthrodesis (and other procedures) by strategically angling locking screws in the second bone fragment after securing the plate to the first fragment. These biomechanical insights offer practical guidance for achieving superior interfragmentary compression and potentially reducing the risk of nonunion in clinical practice.

  • Assessing the Predictive Accuracy of Popular Comorbidity Indices in Total Ankle Arthroplasty Outcomes

    by Weston E. McDonald, Alexander S. Guareschi, Joshua Morningstar, Christopher E. Gross, Daniel J. Scott

    Background: This study aims to investigate the validity of the Charlson Comorbidity Index (CCI) and Elixhauser Comorbidity Index (ECI) as predictive tools for adverse outcomes following total ankle arthroplasty (TAA). Methods: The Nationwide Readmissions Database (NRD) was queried from 2015 to 2020 to identify 29 705 patients undergoing primary TAA. Patients’ comorbidity was measured via CCI and ECI scores, and patients who experienced adverse postoperative outcomes (any complication, readmission, mortality, extended length of stay (LOS), and adverse discharge) were identified. Results: Both the ECI and CCI comorbidity indices predicted mortality with excellent accuracy (Area under the Curve [AUC] = 0.88 for both). However, ECI outperformed CCI in predicting complications, extended LOS, and adverse discharge, although both had poor predictive capability for these outcomes. Conclusion: These findings indicate that while ECI and CCI are capable of predicting postoperative mortality following TAA, there is a need for alternative models that better predict other postoperative adverse outcomes. Level of Evidence: Level III; Retrospective cohort study


  • The effect of preoperative osteoporosis on postoperative outcomes following total ankle arthroplasty

    by Grace Bennfors, Ronit Kulkarni, Joshua Morningstar, Richard J. Friedman, Christopher E. Gross, Daniel J. Scott


  • Assessing the costs of midfoot arthrodesis: A retrospective cohort study

    by William Newton, Andrew Rowley, Cody Ashy, Caroline P. Hoch, Joshua L. Morningstar, Christopher E. Gross, Daniel J. Scott

  • Preoperative opioid dependence associated with increased costs and wound dehiscence following total ankle arthroplasty

    by Weston E. McDonald, Alexander S. Guareschi, Joshua L. Morningstar, Richard J. Friedman, Christopher E. Gross, Daniel J. Scott


  • Design Rational for Total Ankle Arthroplasty: An Update

    by Christopher E. Gross, Andrew R. Hsu, Daniel J. Scott, Ariel Palanca

    The design of total ankle arthroplasty (TAA) systems is rapidly evolving as device companies try to keep pace with the expansion of surgical indications and a refinement of techniques for TAA. Even since the publication of the latest “update,” published in 2018, three new designs and three updates on preexisting third-generation implants came onto the market. Improvements in third-generation TAA systems include minimal bone resection, retaining ligamentous support, and anatomic balancing. Fourth-generation systems use 3D printing technology, improved talus and tibia designs based on CT scans of arthritic and normal ankles, and include patient-specific instrumentation. We will then explore the short-term and mid-term outcomes of the previously discussed six TAA systems—INBONE, INFINITY, INVISION (Stryker), Salto-Talaris (Smith and Nephew), Scandinavian Total Ankle Arthroplasty (Enovis), Trabecular Metal Total Ankle (Zimmer Biomet), and VANTAGE (Exactech). As more research pours in regarding mid- to long-term outcomes of these implants, it is important to assess the design rationale and summarize current outcome data for these implants.


  • A systematic review of outcomes of total ankle arthroplasty with INBONE II

    by Cody C. Ashy, Jared J. Reid, Joshua L. Morningstar, Emily Brennan, Daniel J. Scott, Christopher E. Gross